Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Long

Showing results (21-30 of 81) with videos related to

Pageof 9
Sort By:
Neuroscience and Biobehavioral Reviews|April 13, 2023
A systematic review and meta-analysis of depression and apathy frequency in adult-onset Huntington's diseaseMelanie L Clark, Julie Abimanyi-Ochom, Ha Le, et al.
Gene Therapy|January 12, 2021
Validation of an IFN-gamma ELISpot assay to measure cellular immune responses against viral antigens in non-human primatesFan Yang, Kathryn Patton, Theresa Kasprzyk, et al.
Brain Impairment : a Multidisciplinary Journal of the Australian Society for the Study of Brain Impairment|April 3, 2024
What does cognitive screening reveal about early cognitive performance following endovascular clot retrieval and intravenous thrombolysis in acute ischaemic stroke?Sam Humphrey, Kerryn E Pike, Brian Long, et al.
Clinical Therapeutics|December 14, 2016
Long-term Immunogenicity of Elosulfase Alfa in the Treatment of Morquio A Syndrome: Results From MOR-005, a Phase III Extension StudyBrian Long, Troy Tompkins, Celeste Decker, et al.
Molecular Genetics and Metabolism|March 13, 2018
Safety, immunogenicity, and clinical outcomes in patients with Morquio A syndrome participating in 2 sequential open-label studies of elosulfase alfa enzyme replacement therapy (MOR-002/MOR-100), representing 5 years of treatmentChristian Hendriksz, Saikat Santra, Simon A Jones, et al.
Communications Biology|August 25, 2021
Comprehensive in situ mapping of human cortical transcriptomic cell typesChristoffer Mattsson Langseth, Daniel Gyllborg, Jeremy A Miller, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 24, 2007
Identical beta cell-specific CD8(+) T cell clonotypes typically reside in both peripheral blood lymphocyte and pancreatic isletsCarmen P Wong, Rosemary Stevens, Brian Long, et al.
Advances in Anatomy, Embryology, and Cell Biology|May 22, 2016
Bioimage Informatics for Big DataHanchuan Peng, Jie Zhou, Zhi Zhou, et al.
Immunotherapy|June 29, 2021
Ruxolitinib, a JAK1/JAK2 selective inhibitor, ameliorates acute and chronic steroid-refractory GvHD mouse modelsEduardo Huarte, Michael Peel, Ashish Juvekar, et al.
Journal of the International Neuropsychological Society : JINS|February 2, 2026
Identifying key potential outcomes of neuropsychological assessment: An Australian expert consensus studyDana Wong, Sai-Priya Paladee, Joanne Wrench, et al.
Pageof 9

Showing results (21-30 of 81) with videos related to

Sort By:
Pageof 9
Neuroscience and Biobehavioral Reviews|April 13, 2023
A systematic review and meta-analysis of depression and apathy frequency in adult-onset Huntington's diseaseMelanie L Clark, Julie Abimanyi-Ochom, Ha Le, et al.
Gene Therapy|January 12, 2021
Validation of an IFN-gamma ELISpot assay to measure cellular immune responses against viral antigens in non-human primatesFan Yang, Kathryn Patton, Theresa Kasprzyk, et al.
Brain Impairment : a Multidisciplinary Journal of the Australian Society for the Study of Brain Impairment|April 3, 2024
What does cognitive screening reveal about early cognitive performance following endovascular clot retrieval and intravenous thrombolysis in acute ischaemic stroke?Sam Humphrey, Kerryn E Pike, Brian Long, et al.
Clinical Therapeutics|December 14, 2016
Long-term Immunogenicity of Elosulfase Alfa in the Treatment of Morquio A Syndrome: Results From MOR-005, a Phase III Extension StudyBrian Long, Troy Tompkins, Celeste Decker, et al.
Molecular Genetics and Metabolism|March 13, 2018
Safety, immunogenicity, and clinical outcomes in patients with Morquio A syndrome participating in 2 sequential open-label studies of elosulfase alfa enzyme replacement therapy (MOR-002/MOR-100), representing 5 years of treatmentChristian Hendriksz, Saikat Santra, Simon A Jones, et al.
Communications Biology|August 25, 2021
Comprehensive in situ mapping of human cortical transcriptomic cell typesChristoffer Mattsson Langseth, Daniel Gyllborg, Jeremy A Miller, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 24, 2007
Identical beta cell-specific CD8(+) T cell clonotypes typically reside in both peripheral blood lymphocyte and pancreatic isletsCarmen P Wong, Rosemary Stevens, Brian Long, et al.
Advances in Anatomy, Embryology, and Cell Biology|May 22, 2016
Bioimage Informatics for Big DataHanchuan Peng, Jie Zhou, Zhi Zhou, et al.
Immunotherapy|June 29, 2021
Ruxolitinib, a JAK1/JAK2 selective inhibitor, ameliorates acute and chronic steroid-refractory GvHD mouse modelsEduardo Huarte, Michael Peel, Ashish Juvekar, et al.
Journal of the International Neuropsychological Society : JINS|February 2, 2026
Identifying key potential outcomes of neuropsychological assessment: An Australian expert consensus studyDana Wong, Sai-Priya Paladee, Joanne Wrench, et al.
Pageof 9